US Patent 10472406 Insulin analogues with selective signaling properties and reduced mitogenicity
Patent 10472406 was granted and assigned to Case Western Reserve University on November, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10472406 Insulin analogues with selective signaling properties and reduced mitogenicity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
